DAVID GRAHAM to Patient Compliance
This is a "connection" page, showing publications DAVID GRAHAM has written about Patient Compliance.
Connection Strength
0.209
-
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8.
Score: 0.047
-
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis. 2004 Jun; 36(6):384-7.
Score: 0.045
-
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther. 2000 Jun; 14(6):745-50.
Score: 0.034
-
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1995 Sep; 90(9):1415-8.
Score: 0.024
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
Score: 0.022
-
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb; 102(2):493-6.
Score: 0.019
-
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.
Score: 0.012
-
Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jul; 12(7):635-9.
Score: 0.007